| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_571b8abacacea64d3f7089d0983b8b3b |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-34 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-34 |
| filingDate |
1982-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
1982-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
GB-2094793-A |
| titleOfInvention |
Heterocyclic prostaglandin analogues |
| abstract |
Compounds of the general formula <IMAGE> (wherein A represents a group of formula -CH = CH- (in either the cis- or trans-configuration), -(CH2)2- or -(CH)3-; and Z represents a C4-6 alkyl group or a group of formula <IMAGE> in which R represents a C5-7 alkyl or C5-7 cycloalkyl group) and salts have been found to have an inhibitory effect on blood platelet aggregation and are therefore useful in medical therapy eg for the treatment of thromboembloic conditions. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-D751407-S
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-D802427-S
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-D803062-S
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-D722879-S
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-D736089-S
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-D736637-S
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011173926-A |
| priorityDate |
1981-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |